David Rotllant Pozo

Title: David Rotllant Pozo: Innovator in Multiple Sclerosis Treatment

Introduction

David Rotllant Pozo is a notable inventor based in Cornellà de Llobregat, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. His innovative approach has garnered attention in the scientific community.

Latest Patents

David holds a patent for a method of treating multiple sclerosis employing a LSD1-inhibitor. The patent details methods for treating multiple sclerosis using (−) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof. This invention represents a promising advancement in therapeutic options for patients suffering from this debilitating condition.

Career Highlights

David is currently associated with Oryzon Genomics S.A., a company focused on developing innovative therapies. His work at Oryzon has positioned him as a key player in the research and development of new treatments for neurological disorders.

Collaborations

David collaborates with talented professionals in his field, including Tamara Maes and Cristina Mascarò Crusat. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in medical innovation.

Conclusion

David Rotllant Pozo is a pioneering inventor whose work in treating multiple sclerosis showcases his commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of innovation in medicine.